2024
The Predictive Value of Aortic Calcification on Computed Tomography for Major Cardiovascular Events
Chlorogiannis D, Pargaonkar S, Apostolos A, Vythoulkas-Biotis N, Kokkinidis D, Nagraj S. The Predictive Value of Aortic Calcification on Computed Tomography for Major Cardiovascular Events. Journal Of Clinical Medicine 2024, 13: 4019. PMID: 39064058, PMCID: PMC11277087, DOI: 10.3390/jcm13144019.Peer-Reviewed Original ResearchTranscatheter aortic valve implantationPrediction of MACEAortic calcificationComputed tomographyPredictive valueCardiovascular diseaseAbdominal aortic calcificationTranscatheter aortic valve implantation proceduresDescending thoracic aortaAdverse cardiovascular eventsIdentification of patientsPrevalence of cardiovascular diseaseExtra-coronary calcificationAortic valve implantationAtherosclerotic cardiovascular diseaseMinimally invasive percutaneous proceduresInvasive percutaneous proceduresThoracic calcificationDiagnostic modalitiesAortic archRisk stratificationAortic valveCardiovascular eventsCoronary calcificationThoracic aortaObesity and Transcatheter Aortic Valve Replacement
Seo J, Kharawala A, Borkowski P, Singh N, Akunor H, Nagraj S, Avgerinos D, Kokkinidis D. Obesity and Transcatheter Aortic Valve Replacement. Journal Of Cardiovascular Development And Disease 2024, 11: 169. PMID: 38921670, PMCID: PMC11203863, DOI: 10.3390/jcdd11060169.Peer-Reviewed Original ResearchTranscatheter aortic valve replacementTranscatheter aortic valve replacement patientsImprove survival outcomesAortic valve replacementAssociation of obesityImpact of obesityValve replacementPeriprocedural complicationsObesity paradoxSurvival outcomesObesity prevalenceMetabolic profileObesity's roleRisk factorsObesityCardiovascular diseasePatientsOutcomesRNA Interference-based Therapies for the Reduction of Cardiovascular Risk
Nazarenko N, Seo J, Nagraj S, Palaiodimos L, Kokkinidis D. RNA Interference-based Therapies for the Reduction of Cardiovascular Risk. Current Molecular Pharmacology 2024, 17: e18761429264553. PMID: 38449067, DOI: 10.2174/0118761429264553231204115314.Peer-Reviewed Original ResearchLDL-C levelsLDL-CReduction of cardiovascular riskRNA interference-based therapiesSignificant cardiovascular eventsLDL-C level reductionRisk of cardiovascular diseaseCases of coronary artery diseaseNon-modifiable risk factorsCoronary artery diseasePrevalent risk factorIncidence of CVDLowering lipid levelsRisk factors of heart diseaseCardiovascular eventsFactors of heart diseaseMortality benefitCardiovascular riskArtery diseaseRisk factorsHeart diseaseLipid levelsCardiovascular diseasePrevent 2Lifestyle factors
2023
Inflammation, anti-inflammatory agents, and the role of colchicine in carotid artery stenosis.
Chlorogiannis D, Pargaonkar S, Papanagiotou P, Bakogiannis N, Bakoyiannis C, Kokkinidis D. Inflammation, anti-inflammatory agents, and the role of colchicine in carotid artery stenosis. Vasa 2023, 53: 4-12. PMID: 38079179, DOI: 10.1024/0301-1526/a001104.Peer-Reviewed Original ResearchConceptsCarotid artery stenosisArtery stenosisAnti-inflammatory medicationsRole of inflammationCoronary artery diseaseAnti-inflammatory agentsRole of colchicineArtery diseaseOngoing trialsOptimal treatmentCardiovascular diseaseStenosis developmentMedicationsInflammationAvailable evidenceMajor causeStenosisDiseaseColchicineMorbidityPatientsMortalityProgressionTrials